Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma.
Ning LiShao-Hua RenYa-Fei QinBo ShaoHong QinZhaobo WangHong-da WangGuang-Ming LiYang-Lin ZhuCheng-Lu SunJing-Yi ZhangGang-Gang ShiXing-Wei AnHao WangPublished in: BioMed research international (2022)
A nomogram based on the four-pyroptosis gene signature was a novel tool to predict the effectiveness of immunotherapy for HCC. Therefore, individualized treatment targeting the pyroptosis genes may influence TIME and play an essential role in improving the prognosis in HCC patients.
Keyphrases
- genome wide
- nlrp inflammasome
- genome wide identification
- end stage renal disease
- ejection fraction
- copy number
- newly diagnosed
- randomized controlled trial
- prognostic factors
- genome wide analysis
- squamous cell carcinoma
- gene expression
- peritoneal dialysis
- dna methylation
- cancer therapy
- combination therapy
- patient reported